Early changes in bleeding perception and quality of life in children and adolescents receiving emicizumab prophylaxis for severe haemophilia A without inhibitor

Haemophilia. 2023 Jan;29(1):397-400. doi: 10.1111/hae.14724. Epub 2022 Dec 16.
No abstract available

Keywords: bleeding disorders; emicizumab; haemophilia; quality of life.

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Antibodies, Bispecific* / pharmacology
  • Antibodies, Bispecific* / therapeutic use
  • Child
  • Factor VIII / therapeutic use
  • Hemophilia A* / complications
  • Hemophilia A* / drug therapy
  • Hemorrhage / drug therapy
  • Hemorrhage / prevention & control
  • Humans
  • Perception
  • Quality of Life

Substances

  • emicizumab
  • Antibodies, Bispecific
  • Factor VIII